Edwards Lifesciences has climbed 24% in the past month as strong earnings and robust heart valve sales lifted investor confidence. The move also reflects a broa

Edwards Lifesciences has climbed 24% in the past month as strong earnings and robust heart valve sales lifted investor confidence. The move also reflects a broader demographic tailwind: an aging US population is driving demand for advanced cardiac care.